Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Immunotherapy symbols : NVSEF save search
Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.46%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.49%
H: 0.6%
C: -0.83%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.15%
H: 1.88%
C: -1.17%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.24%
H: 1.43%
C: 1.43%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.32%
H: 0.93%
C: 0.38%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.36%
H: 0.98%
C: 0.72%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.68%
H: 0.87%
C: 0.1%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.32%
H: 0.44%
C: 0.26%
america cancer immunotherapy market
Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.67%
H: 1.17%
C: 0.85%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 1.16%
H: 0.14%
C: -1.89%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.11%
H: 0.5%
C: -1.78%
cancer global immunotherapy market
Global Immuno-oncology Market Report to 2028: An Increase in the Research and Development in Cancer Immunotherapy Will Be Driving Growth
Published: 2022-11-28 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -2.51%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.38%
H: 1.09%
C: 0.87%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: -0.68%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.29%
H: 0.45%
C: -0.32%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.65%
H: 0.83%
C: -0.03%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.49%
H: 1.67%
C: 0.64%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: -0.06%
research global immunotherapy report cancer growth market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA M | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO | $10.1 -2.6% -2.67% 250K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.7101 -1.18% -1.2% 700K
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.34%
H: 1.72%
C: 0.95%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 0.0%
H: 2.28%
C: -2.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
immunotherapy report therapy cancer market treatment
Global Cancer Immunotherapy Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-04-06 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 4.21%
H: 0.0%
C: -0.61%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.45%
H: 0.46%
C: 0.19%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -1.11%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.39%
H: 0.53%
C: 0.44%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.27%
H: 2.95%
C: 1.12%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.05%
H: 2.52%
C: 2.49%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.74%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.35%
H: 2.64%
C: 2.45%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.29%
H: 1.42%
C: 0.98%
immunotherapy cancer market
Drugs for Immunotherapy Global Market Report 2022
Published: 2022-03-25 (Crawled : 18:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -6.55%
H: 7.81%
C: 7.56%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.28%
H: 1.09%
C: 0.18%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.58%
H: 1.16%
C: 0.23%
immunotherapy report market drug
Cellular Immunotherapy Global Market Report 2022
Published: 2022-03-25 (Crawled : 14:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: 0.0%
immunotherapy report market
Billions Flowing into Cancer Immunotherapy as Market Responds to Impressive Market Potential
Published: 2022-01-24 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: -1.88%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -3.71%
H: 0.66%
C: 0.66%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -2.45%
H: 0.18%
C: -0.02%
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: -1.05%
H: 1.59%
C: -3.17%
EXAS | $63.24 -0.46% -0.46% 1.2M
|
Health Technology
|
| O: -2.0%
H: 3.27%
C: 2.91%
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: -2.95%
H: 2.45%
C: 1.98%
immunotherapy potential therapy cancer market
Novartis strengthens immunotherapy pipeline with option, collaboration and license agreement with BeiGene for TIGIT inhibitor ociperlimab
Published: 2021-12-20 (Crawled : 23:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.03%
H: 0.24%
C: -0.15%
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 8.83%
H: 0.11%
C: -4.16%
novartis license immunotherapy therapy collaboration
Immunotherapy Drugs Market Size to Reach Revenues of USD 326.36 Billion by 2026 - Arizton
Published: 2021-10-12 (Crawled : 17:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.11%
H: 0.34%
C: -0.33%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.44%
H: 0.16%
C: -0.82%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.72%
H: 0.1%
C: -0.06%
immunotherapy therapy drug
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.